Aurobindo Pharma's Eugia facility receives 'Official Action Indicated' status from US FDA.
Aurobindo Pharma's subsidiary, Eugia Pharma Specialities, has received an 'Official Action Indicated' status from the US FDA for its formulation manufacturing facility, Unit III, following an inspection in January-February. Aurobindo Pharma noted it remains dedicated to working with the USFDA to improve compliance. 'OAI' indicates unacceptable conditions or responses were found during the inspection.
May 25, 2024
3 Articles